NCT01809691
Clinical Trial Information
Trial Number: NCT01809691 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
Study ID:
S1216
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01809691-D2 | There are two dataset submissions associated with this publication: NCT01809691-D1 and NCT01809691-D2. These datasets contain the results reported in the Journal of Clinical Oncology (Agarwal et al., Journal of Clinical Oncology, 2022). This toxicity dataset contains event-level information (one row per patient per adverse event experienced on trial). |
| NCT01809691-D1 | There are two dataset submissions associated with this publication: NCT01809691-D1 and NCT01809691-D2. These datasets contain the results reported in the Journal of Clinical Oncology (Agarwal et al., Journal of Clinical Oncology, 2022). This clinical dataset contains patient-level data (one row per patient), including eligibility, evaluability, treatment, demographic, and baseline information. It also contains assessment data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®